Jacobs Levy Equity Management
CDLX icon

Jacobs Levy Equity Management’s Cardlytics CDLX Stock Holding History

Jacobs Levy Equity Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,310
Closed -$55.8K – 969
2026
Q1 		$55.8K Sell
5,310
-58,552
-92% -$571K ﹤0.01% 948
2025
Q4 		$734K Buy
+63,862
New +$986K ﹤0.01% 739
2025
Q3 		– Sell
-14,548
Closed -$239K – 987
2025
Q2 		$239K Sell
14,548
-56
-0.4% -$967 ﹤0.01% 966
2025
Q1 		$266K Sell
14,604
-10,801
-43% -$309K ﹤0.01% 996
2024
Q4 		$943K Sell
25,405
-6,359
-20% -$243K ﹤0.01% 722
2024
Q3 		$1.02M Buy
31,764
+11,396
+56% +$632K ﹤0.01% 719
2024
Q2 		$1.67M Sell
20,368
-2,054
-9% -$222K 0.01% 637
2024
Q1 		$3.25M Sell
22,422
-20,161
-47% -$1.7M 0.01% 505
2023
Q4 		$3.92M Buy
42,583
+21,589
+103% +$2.19M 0.02% 476
2023
Q3 		$3.46M Sell
20,994
-15,092
-42% -$1.96M 0.02% 446
2023
Q2 		$2.28M Sell
36,086
-5,739
-14% -$348K 0.01% 542
2023
Q1 		$1.42M Buy
41,825
+291
+0.7% +$15.2K 0.01% 634
2022
Q4 		$2.4M Buy
+41,534
New +$2.57M 0.02% 517
2021
Q1 		– Sell
-433
Closed -$618K – 1024
2020
Q4 		$618K Buy
+433
New +$462K 0.01% 818

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Jacobs Levy Equity Management's CDLX Position: Q2 2026 in Review

Jacobs Levy Equity Management sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 5,310 shares — an estimated $55.8K sold.

Jacobs Levy Equity Management first reported a position in CDLX in Q4 2020 and held it in 14 quarters. The position peaked at $3.92M in Q4 2023. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Jacobs Levy Equity Management reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 5,310 Cardlytics shares in Q2 2026, an estimated $55.8K.
  • Jacobs Levy Equity Management first reported a position in Cardlytics in Q4 2020 and held it in 14 quarters.
  • Jacobs Levy Equity Management's Cardlytics position peaked at $3.92M in Q4 2023.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.